Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 39 - General protective or antinoxious agents
Patents for A61P 39 - General protective or antinoxious agents (19,019)
11/2005
11/03/2005US20050245537 Use of compounds having ccr antagonism
11/03/2005US20050244508 Anti-spasmodic comprising xenon
11/02/2005EP1591020A1 Compositions containing coenzyme q10
11/02/2005CN1691949A Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases
11/02/2005CN1691948A Adsorbent for oral administration
11/02/2005CN1225260C Rose extract and its preparation
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
10/2005
10/27/2005WO2005099738A1 Laminaria algal extract for use as a therapeutic agent
10/27/2005WO2005046567B1 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
10/27/2005US20050239896 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke, depression, glaucoma
10/27/2005US20050238578 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders
10/27/2005DE10117834B4 Verwendung von Phosphotyrosin zum Schutz von biologischem Material sowie kosmetische Zusammensetzung und Kultivierungsmedium Use of phosphotyrosine on the protection of biological material and cosmetic composition and culture medium
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1587482A2 Anti-inflammatory compositions and uses thereof
10/26/2005EP1299406B1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same
10/26/2005CN1688578A Phosphodiesterase 4 inhibitors
10/25/2005US6958357 Central nervous system disorders; antiallergens; respiratory system disorders
10/25/2005US6958148 microparticle comprising active agent and polymer having transglutaminase substrate reactive groups, wherein reactive groups are surface available, and polymer comprises amino acids having at least three contiguous linked glutamines; drug delivery
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097151A1 Antioxidant composition and products containing the same
10/20/2005WO2005096806A1 Rice plant having vaccine gene transferred thereinto
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005CA2806465A1 Ion binding polymers and uses thereof
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1345616A4 Reducing cellular damage in the human body
10/19/2005EP1200095B1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances
10/19/2005CN1683360A Process for extracting folium mori flavone
10/19/2005CN1682950A Composition containing nucleoside and its preparing method
10/19/2005CN1682750A Disodium adenosine triphosphate solid composition for injection and its preparing method
10/19/2005CN1682723A Scopolamine hydrobromide dry powder inhalant for nose and preparing method
10/19/2005CN1682701A Self microemulsifying preparation of curcumin and its preparing process
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005094844A1 Adsorbent for oral administration, preventive or remedy for kidney disease and preventive or remedy for liver disease
10/13/2005US20050228171 Purification method
10/13/2005US20050227957 Therapy for oxidation stresses; complex of drug and enzyme mimetics; lipophilic cation moiety covalently bonded to glutathione peroxidase mimetic moiety is selected from the group consisting of: benzisoselenazolones, diaryl diselenides and diaryl selenides
10/13/2005US20050226901 Dermatological composition
10/13/2005CA2561730A1 Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
10/13/2005CA2560826A1 Antioxidant-promoting herbal extract compositions for alleviating oxidative stress in a mammal
10/12/2005CN1680353A Rice bean flavone extracts and their use
10/12/2005CN1679914A Medicinal composition of induced glutathione and ebeselen
10/12/2005CN1679912A Extraction of liuwei Dihuang polysaccharide, products and use thereof
10/12/2005CN1679903A Multifuntional health-care oral liquid
10/12/2005CN1679897A Bioamino acid capsules and preparation thereof
10/12/2005CN1679816A Freeze-dried powder injection of Tianjihuang and its making method
10/12/2005CN1679638A Preparation and use of antioxidant component from protein liquid of living scorpion
10/12/2005CN1679611A Compound preparation of piracetam and its use
10/12/2005CN1679609A Compound energy mistura fat-soluble vitamins adult preparation and use thereof
10/12/2005CN1679608A Compound preparation of inosine, triphosphoadenosine and vitamin C and use thereof
10/12/2005CN1222297C Combined cartilage and plant extract composition
10/12/2005CN1222288C Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
10/11/2005CA2341276C Human anti-factor ix/ixa antibodies
10/06/2005US20050222253 Anti-cancer nitro- and thia-fatty acids
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050220884 Free-flowing, powdery composition containing alpha-liponic acid (derivates)
10/06/2005CA2560843A1 Novel method of neuroprotection by pharmacological inhibition of amp-activated protein kinase
10/05/2005EP1385536B1 Preparations containing a combination of vitamin e and afamin
10/05/2005EP1263430B1 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
10/05/2005EP1163231B1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
10/05/2005CN1678606A Novel crystals
10/05/2005CN1678572A Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
10/05/2005CN1678341A Use of erythopoietin
10/05/2005CN1676158A Pine bark formulation and its preparing method
10/05/2005CN1221190C Composition and method for smoke detoxification
10/04/2005US6951890 Preventing and/or treating cardiovascular disease and/or associated heart failure
09/2005
09/29/2005US20050215869 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050214903 O-superfamily conotoxin peptides
09/29/2005US20050214334 Composition for topical substance delivery
09/29/2005DE202005010821U1 Piece of soap contains stone(s), e.g. healing stones such as orange carnelian or green aventurine in translucent or clear, optionally scented soap
09/29/2005CA2558020A1 Use of renin inhibitors in therapy
09/28/2005EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
09/28/2005CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
09/28/2005CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
09/28/2005CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
09/28/2005CN1674907A Use of reboxetine for the treatment of hot flashes
09/28/2005CN1672729A Mung bean bolus producing process
09/28/2005CN1220488C Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction
09/27/2005CA2241825C New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
09/22/2005WO2005087224A1 Composition for stabilizing epigallocatechin gallate (egcg) in water phase and preparation method thereof
09/22/2005WO2005046567A3 Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
09/22/2005US20050209192 Autoimmune disorders; modulating protein kinase C activity
09/22/2005CA2556223A1 Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
09/21/2005EP1576960A1 Composition containing green and yellow vegetables and light-colored vegetables
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005CN1671744A Low molecular weight oversulfated polysaccharide
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1671403A Dioxin elimination promoter
09/21/2005CN1219523C Buccal lozenge of notoginseng flower
09/15/2005US20050201997 Dioxin elimination promoter
09/15/2005US20050201955 Use of compatible solutes for inhibiting the release of ceramides
09/15/2005CA2598687A1 Flavonoids
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572240A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/14/2005CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress
1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 191